Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Briel

Showing results (131-140 of 288) with videos related to

Pageof 29
Sort By:
Journal of Clinical Epidemiology|September 22, 2024
Resource use and costs of investigator-sponsored randomized clinical trials in Switzerland, Germany, and the United Kingdom: a metaresearch studyAlexandra Griessbach, Benjamin Speich, Alain Amstutz, et al.
BMJ Open|January 24, 2016
Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensusDirk Bassler, Katharina F Mueller, Matthias Briel, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 28, 2015
Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinomaRebecca A Dumont, Daniela Seiler, Nicolas Marincek, et al.
Trials|April 16, 2020
COVID-19 randomised trial protocols: rapid publication without barriersShaun Treweek, Peter Jüni, Tianjing Li, et al.
BMJ (Clinical Research Ed.)|February 21, 2007
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trialsMartin A Walter, Matthias Briel, Mirjam Christ-Crain, et al.
Journal of Translational Medicine|January 17, 2013
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation studyNicolas Marincek, Ann-Catherine Jörg, Philippe Brunner, et al.
Systematic Reviews|May 3, 2013
A protocol for a systematic review on the impact of unpublished studies and studies published in the gray literature in meta-analysesChristine Schmucker, Annette Bluemle, Matthias Briel, et al.
Plos One|July 18, 2017
Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research qualityBelinda von Niederhäusern, Stefan Schandelmaier, Marie Mi Bonde, et al.
The Cochrane Database of Systematic Reviews|December 8, 2021
Monitoring strategies for clinical intervention studiesKatharina Klatte, Christiane Pauli-Magnus, Sharon B Love, et al.
The Cochrane Database of Systematic Reviews|April 15, 2011
Randomisation to protect against selection bias in healthcare trialsJan Odgaard-Jensen, Gunn E Vist, Antje Timmer, et al.
Pageof 29

Showing results (131-140 of 288) with videos related to

Sort By:
Pageof 29
Journal of Clinical Epidemiology|September 22, 2024
Resource use and costs of investigator-sponsored randomized clinical trials in Switzerland, Germany, and the United Kingdom: a metaresearch studyAlexandra Griessbach, Benjamin Speich, Alain Amstutz, et al.
BMJ Open|January 24, 2016
Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensusDirk Bassler, Katharina F Mueller, Matthias Briel, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 28, 2015
Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinomaRebecca A Dumont, Daniela Seiler, Nicolas Marincek, et al.
Trials|April 16, 2020
COVID-19 randomised trial protocols: rapid publication without barriersShaun Treweek, Peter Jüni, Tianjing Li, et al.
BMJ (Clinical Research Ed.)|February 21, 2007
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trialsMartin A Walter, Matthias Briel, Mirjam Christ-Crain, et al.
Journal of Translational Medicine|January 17, 2013
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation studyNicolas Marincek, Ann-Catherine Jörg, Philippe Brunner, et al.
Systematic Reviews|May 3, 2013
A protocol for a systematic review on the impact of unpublished studies and studies published in the gray literature in meta-analysesChristine Schmucker, Annette Bluemle, Matthias Briel, et al.
Plos One|July 18, 2017
Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research qualityBelinda von Niederhäusern, Stefan Schandelmaier, Marie Mi Bonde, et al.
The Cochrane Database of Systematic Reviews|December 8, 2021
Monitoring strategies for clinical intervention studiesKatharina Klatte, Christiane Pauli-Magnus, Sharon B Love, et al.
The Cochrane Database of Systematic Reviews|April 15, 2011
Randomisation to protect against selection bias in healthcare trialsJan Odgaard-Jensen, Gunn E Vist, Antje Timmer, et al.
Pageof 29